| |
|
|
|
Galectin Therapeutics Inc.  
|
|
4.16 -0.14 (-0.03%) |
04-22 16:00 |
|
Open: |
4.3 |
Pre close: |
4.3 |
Target:
|
5.50
|
|
High: |
4.3864 |
Low: |
4.11 |
Resistance:
|
4.71
5.20
|
|
Volume: |
323,921 |
Market Cap: |
189M |
Support:
|
3.92
3.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.34
 |
MACD |
MACD(12,26):
|
-0.14 |
|
MA(20): |
4.68 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
4.73 |
Stochastic Oscillator |
%K(14,3):
|
28.50  |
|
MA(250): |
5.03 |
%D(3): |
26.01 |
|
Average Volume(K) |
3-Month: |
39590
|
52-Week |
High:
|
9.49 |
|
10-Days: |
46092 |
Low: |
3.10 |
|
RSI |
RSI(14):
|
34.97 |
Change(%): |
20.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.380 |
Return on Equity (ttm) |
306.7 |
Shares Out. (M) |
45.55 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-228.6 |
Shares Float (M) |
37.81 |
|
EPS Est. Next Year |
-0.520 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.50 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
19.00 |
|
Forward EPS |
-0.690 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
13184.260 |
EBITDA (p.s.) |
0.000 |
P/E |
-10.95 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.18 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.93 |
P/CF |
-18.61 |
|
|
|
|
|
|
